Tim-3 as a diagnostic and prognostic biomarker of osteosarcoma

Osteosarcoma is the most frequent primary bone tumor that affects adolescents and children. However, diagnostic and prognostic biomarkers for osteosarcoma remain lacking. (Tim-3) T-cell immunoglobulin domain and mucin domain-3, which negatively regulates T cell helper (Th1) cells and affects cytokin...

Full description

Bibliographic Details
Main Authors: Wenhui Ge, Jing Li, Wenhao Fan, Delong Xu, Shangfei Sun
Format: Article
Language:English
Published: IOS Press 2017-06-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428317715643
_version_ 1818617526579363840
author Wenhui Ge
Jing Li
Wenhao Fan
Delong Xu
Shangfei Sun
author_facet Wenhui Ge
Jing Li
Wenhao Fan
Delong Xu
Shangfei Sun
author_sort Wenhui Ge
collection DOAJ
description Osteosarcoma is the most frequent primary bone tumor that affects adolescents and children. However, diagnostic and prognostic biomarkers for osteosarcoma remain lacking. (Tim-3) T-cell immunoglobulin domain and mucin domain-3, which negatively regulates T cell helper (Th1) cells and affects cytokine expression, has attracted increasing attention due to its critical role in regulating both adaptive and innate immune cells. In this study, we evaluated serum soluble Tim-3 level in osteosarcoma patients to explore its diagnostic and prognostic value for this particular malignancy. Serum soluble Tim-3 level was measured with enzyme-linked immunosorbent assay in 120 osteosarcoma patients, 120 benign bone tumors patients and 120 healthy controls, followed by analysis of the correlation with clinic pathological characteristics. Receiver operating curves, Kaplan-Meier curves, and log-rank analyses as well as Cox proportional hazard models were used to evaluate the diagnostic and prognostic significance. Serum solubleTim-3 level was remarkably elevated in osteosarcoma patients. Osteosarcoma patients with larger tumor size, late stages and distant metastases were accompanied with higher levels of Tim-3. ROC/AUC analysis indicated thatTim-3 served as a reliable marker to distinguish healthy participants from Tim-3 patients. Osteosarcoma patients with higher Tim-3 had relatively lower survival. Multivariate analyses for overall survival revealed that high serum soluble Tim-3 level was an independent prognostic factor for osteosarcoma. Furthermore, Tim-3 levels of CD8+ and CD4+ T cells were elevated in peripheral circulation of osteosarcoma patients. Therefore, It was indicated in our research that elevated serum soluble Tim-3 level might be a novel potential diagnostic and prognostic biomarker for osteosarcoma patients.
first_indexed 2024-12-16T17:07:06Z
format Article
id doaj.art-8aef1addc50a4a9c954ecdcf492bc9f9
institution Directory Open Access Journal
issn 1423-0380
language English
last_indexed 2024-12-16T17:07:06Z
publishDate 2017-06-01
publisher IOS Press
record_format Article
series Tumor Biology
spelling doaj.art-8aef1addc50a4a9c954ecdcf492bc9f92022-12-21T22:23:33ZengIOS PressTumor Biology1423-03802017-06-013910.1177/1010428317715643Tim-3 as a diagnostic and prognostic biomarker of osteosarcomaWenhui Ge0Jing Li1Wenhao Fan2Delong Xu3Shangfei Sun4Department of Paediatrics, Rizhao People’s Hospital, Rizhao, ChinaDepartment of Orthopedics & Traumatology, Rizhao Hospital of Traditional Chinese Medicine, Rizhao, ChinaDepartment of Orthopedics & Traumatology, Rizhao Hospital of Traditional Chinese Medicine, Rizhao, ChinaDepartment of Orthopedics & Traumatology, Rizhao Hospital of Traditional Chinese Medicine, Rizhao, ChinaDepartment of Paediatrics, Rizhao People’s Hospital, Rizhao, ChinaOsteosarcoma is the most frequent primary bone tumor that affects adolescents and children. However, diagnostic and prognostic biomarkers for osteosarcoma remain lacking. (Tim-3) T-cell immunoglobulin domain and mucin domain-3, which negatively regulates T cell helper (Th1) cells and affects cytokine expression, has attracted increasing attention due to its critical role in regulating both adaptive and innate immune cells. In this study, we evaluated serum soluble Tim-3 level in osteosarcoma patients to explore its diagnostic and prognostic value for this particular malignancy. Serum soluble Tim-3 level was measured with enzyme-linked immunosorbent assay in 120 osteosarcoma patients, 120 benign bone tumors patients and 120 healthy controls, followed by analysis of the correlation with clinic pathological characteristics. Receiver operating curves, Kaplan-Meier curves, and log-rank analyses as well as Cox proportional hazard models were used to evaluate the diagnostic and prognostic significance. Serum solubleTim-3 level was remarkably elevated in osteosarcoma patients. Osteosarcoma patients with larger tumor size, late stages and distant metastases were accompanied with higher levels of Tim-3. ROC/AUC analysis indicated thatTim-3 served as a reliable marker to distinguish healthy participants from Tim-3 patients. Osteosarcoma patients with higher Tim-3 had relatively lower survival. Multivariate analyses for overall survival revealed that high serum soluble Tim-3 level was an independent prognostic factor for osteosarcoma. Furthermore, Tim-3 levels of CD8+ and CD4+ T cells were elevated in peripheral circulation of osteosarcoma patients. Therefore, It was indicated in our research that elevated serum soluble Tim-3 level might be a novel potential diagnostic and prognostic biomarker for osteosarcoma patients.https://doi.org/10.1177/1010428317715643
spellingShingle Wenhui Ge
Jing Li
Wenhao Fan
Delong Xu
Shangfei Sun
Tim-3 as a diagnostic and prognostic biomarker of osteosarcoma
Tumor Biology
title Tim-3 as a diagnostic and prognostic biomarker of osteosarcoma
title_full Tim-3 as a diagnostic and prognostic biomarker of osteosarcoma
title_fullStr Tim-3 as a diagnostic and prognostic biomarker of osteosarcoma
title_full_unstemmed Tim-3 as a diagnostic and prognostic biomarker of osteosarcoma
title_short Tim-3 as a diagnostic and prognostic biomarker of osteosarcoma
title_sort tim 3 as a diagnostic and prognostic biomarker of osteosarcoma
url https://doi.org/10.1177/1010428317715643
work_keys_str_mv AT wenhuige tim3asadiagnosticandprognosticbiomarkerofosteosarcoma
AT jingli tim3asadiagnosticandprognosticbiomarkerofosteosarcoma
AT wenhaofan tim3asadiagnosticandprognosticbiomarkerofosteosarcoma
AT delongxu tim3asadiagnosticandprognosticbiomarkerofosteosarcoma
AT shangfeisun tim3asadiagnosticandprognosticbiomarkerofosteosarcoma